Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Bullboard - Stock Discussion Forum Bright Minds Biosciences Inc DRUG


Primary Symbol: C.DRUG

Bright Minds Biosciences Inc. is a biotechnology company. The Company is focused on developing transformative treatments for neuropsychiatric disorders, epilepsy, and pain. It has a portfolio of next generation serotonin agonists designed to target neurocircuit abnormalities that are responsible for difficult to treat disorders such as treatment resistant epilepsy, treatment resistant... see more

Bullboard (CSE:DRUG)

View:
Post by Iseneschalon Aug 08, 2023 1:49pm

DRUG...it's all about the money Honey

Huge waterfall after the "blowoff"....when the P.O announcement???? Sheeeesh !!!!!!!!!!!!!!!
Post by Iseneschalon Jul 14, 2023 1:02pm

DRUG.... Bleeding like a stuffed pig

What else Go do some more drugs ; )
Post by OTCLegendaon Sep 19, 2022 1:51pm

There’s been a lot of buzz about psychedelic stocks lately

 DRUG has actually kept the gains it made on its mid-August sympathy run.   The psychedelic sector hasn’t caught fire like marijuana and biotechs have in the past couple years.    ...more  
Post by AwareInvestoron Aug 31, 2022 8:54am

Bright Minds Begins Phase 1 Clinical Trials Focused On Treat

Phase 1 trials are officially underway for Bright Minds Biosciences and their lead product, referred to as BMB-101. The firm this morning revealed that it has dosed the first patient under the trial ...more  
Post by AwareInvestoron Aug 24, 2022 8:41am

Bright Minds Biosciences Looks To Raise $4.0 Million Via Ove

After several days of intense volatility, Bright Minds Biosciences is looking to capitalize on the sudden investor interest. The firm has now announced terms for the pricing of its overnight marketed ...more  
Post by cueball40on Aug 19, 2022 11:09am

im in

trying  5k  here   2.17  area   let  her  rip
Post by hashboy18on Aug 18, 2022 1:08pm

shorts get smoked

they shorted it too low and got greedy,huge.ca is also short 6,2 million  anson is feeling pain today
Post by Whitman19on Apr 13, 2022 2:52am

Upcoming catalysts

The next couple of catalysts include the toxicology study for 5HT2A to treat MDD/TRD and the Phase-1 clinical trials for BMB-101 to treat Alzheimer's.  Both are likely to start this quarter
Comment by Whitman19on Mar 25, 2022 2:59am

RE:Bright Minds Moves Into Clinical Development Stage Following

That's wonderful. Just waiting for the stock to take off
Post by AwareInvestoron Mar 14, 2022 7:55am

Bright Minds Moves Into Clinical Development Stage Following

Drug development continues for the Bright Minds Biosciences lead product. The firm this morning published positive results from a recent 28-day toxicity study conducted on its novel formulation, BMB ...more  
The Market Update
{{currentVideo.title}} {{currentVideo.relativeTime}}
< Previous bulletin
Next bulletin >
{{currentVideo.companyName}}
{{currentVideo.intervieweeName}}{{currentVideo.intervieweeTitle}}
< Previous
Next >
Dealroom for high-potential pre-IPO opportunities